Basic Information | Post buying leads | Suppliers |
Name |
ZIRCONIUM(III) LACTATE (1:3) |
EINECS | N/A |
CAS No. | 63919-14-2 | Density | N/A |
PSA | 181.08000 | LogP | -5.64870 |
Solubility | N/A | Melting Point |
N/A |
Formula | C9H9O9•H4OZr | Boiling Point | 227.6°C at 760 mmHg |
Molecular Weight | 372.44 | Flash Point | 109.9°C |
Transport Information | N/A | Appearance | N/A |
Safety | Moderately toxic by intraperitoneal route. When heated to decomposition it emits acrid smoke and irritating fumes. See also ZIRCONIUM COMPOUNDS. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | TLV: 5 mg(Zr)/m3. | |
Synonyms |
N/A |
Product Name: Zirconium(III) lactate (1:3) (CAS NO.63919-14-2)
Molecular Formula: C9H15O9Zr
Molecular Weight: 358.434 g/mol
Mol File: 63919-14-2.mol
Boiling point: 227.6 °C at 760 mmHg
Flash Point: 109.9 °C
Enthalpy of Vaporization: 53.96 kJ/mol
Vapour Pressure: 0.015 mmHg at 25°C
H-Bond Donor: 3
H-Bond Acceptor: 9
Topological Polar Surface Area: 181
Heavy Atom Count: 19
Complexity: 53.5
Undefined Atom StereoCenter Count: 3
ently-Bonded Unit Count: 4
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
rat | LD50 | intraperitoneal | 670mg/kg (670mg/kg) | American Industrial Hygiene Association Journal. Vol. 24, Pg. 131, 1963. | |
rat | LD50 | oral | > 10gm/kg (10000mg/kg) | American Industrial Hygiene Association Journal. Vol. 24, Pg. 131, 1963. | |
women | TDLo | skin | 20ug/kg (0.02mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | JAMA, Journal of the American Medical Association. Vol. 190, Pg. 940, 1964. |
Moderately toxic by intraperitoneal route. When heated to decomposition it emits acrid smoke and irritating fumes. See also ZIRCONIUM COMPOUNDS.
OSHA PEL: TWA 5 mg(Zr)/m3; STEL 10 mg(Zr)/m3
ACGIH TLV: TWA 5 mg(Zr)/m3; STEL 10 mg(Zr)/m3; Not Classifiable as a Human Carcinogen
DFG MAK: 1 mg(Zr)/m3
Zirconium(III) lactate (1:3) ,its CAS NO. is 63919-14-2,the synonyms is Lactic acid, zirconium salt (3:1) .